Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

5.17
Delayed Data
As of 4:00pm ET
 +0.23 / +4.66%
Today’s Change
3.50
Today|||52-Week Range
36.85
-42.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$228.8M

Company Description

Chimerix, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.

Contact Information

Chimerix, Inc.
2505 Meridian Parkway
Durham North Carolina 27713
P:(919) 806-1074
Investor Relations:
(919) 287-4125

Employees

Shareholders

Other institutional38.70%
Mutual fund holders33.42%
Individual stakeholders19.40%

Top Executives

M. Michelle BerreyPresident, Chief Executive Officer & Director
Timothy W. TrostChief Financial Officer, Secretary & Senior VP
Joseph F. RutledgeChief Information Officer & VP-IT
William Garrett NicholsChief Medical Officer
Linda M. RichardsonChief Commercial Officer